Eli Lilly and Company (NYSE: LLY) reported its fourth quarter 2025 earnings results today. Revenue increased 43% year-over-year to $19.3 billion. Reported net income increased 50% to $6.6 billion, or $7.39 per share, compared to last year. Adjusted EPS rose 42% to $7.54. For fiscal year 2026, LLY expects revenue of $80-83 billion and adjusted EPS […]
Eli Lilly and Company (NYSE: LLY) reported its fourth quarter 2025 earnings results today. Revenue increased 43% year-over-year to $19.3 billion. Reported net income increased 50% to $6.6 billion, or $7.39 per share, compared to last year. Adjusted EPS rose 42% to $7.54. For fiscal year 2026, LLY expects revenue of $80-83 billion and adjusted EPS […]
Eli Lilly and Company (NYSE: LLY) reported its fourth quarter 2025 earnings results today.
Revenue increased 43% year-over-year to $19.3 billion.
Reported net income increased 50% to $6.6 billion, or $7.39 per share, compared to last year. Adjusted EPS rose 42% to $7.54.
For fiscal year 2026, LLY expects revenue of $80-83 billion and adjusted EPS of $33.50-35.00.
